Vitreous Levels of Pigment Epithelium–Derived Factor and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion

REFERENCES

• Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology. 1979;86:1931–1942.
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology. 1983;90:458–474.
   PubMed Web of Science ®Google Scholar
• Gutman FA, Zegarra H. Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol. 1984;28:462–470.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116:87–93.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, et al. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. Eur J Ophthalmol. 2010;20:402–409.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, et al. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular edema and central retinal vein occlusion. Acta Ophthalmol. 2010:88:646–651.
   PubMed Web of Science ®Google Scholar
• Steele FR, Chader GJ, Johnson LV, et al. Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 1993;90:1526–1530.
   PubMed Web of Science ®Google Scholar
• Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science. 1999;285:245–248.
   PubMed Web of Science ®Google Scholar
• Stellmach V, Crawford SE, Zhou W, et al. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A. 2001;98:2593–2597.
   PubMed Web of Science ®Google Scholar
• Liu H, Ren JG, Cooper WL, et al. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA. 2004;101:6605–6610.
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Nakamura S, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2006;113:294–301.
   PubMed Web of Science ®Google Scholar
• Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina. 2006;26:279–284.
   PubMed Web of Science ®Google Scholar
• Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol. 2007;143:601–606.
   PubMed Web of Science ®Google Scholar
• Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator. Mol Ther. 2008;16:791–799.
   PubMed Web of Science ®Google Scholar
• Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol. 1999;97:465–469.
   PubMed Web of Science ®Google Scholar
• Leizaola-Fernandez C, Suarez-Tata L, Quiroz-Mercado H, et al. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol. 2005;5:10.
   PubMedGoogle Scholar
• Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256–261.
   PubMed Web of Science ®Google Scholar
• Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2006;244:309–315.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Yamasaki M, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular edema in branch retinal vein occlusion. Eye. 2008;22:42–48.
   PubMed Web of Science ®Google Scholar
• Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol. 1993;111:1087–1095.
   PubMedGoogle Scholar
• Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology. 1995;102:1425–1433.
   PubMed Web of Science ®Google Scholar
• Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol. 1997;115:486–491.
   PubMed Web of Science ®Google Scholar
• Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol. 2000;129:487–494.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Northrup JM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995;113:1538–1544.
   PubMed Web of Science ®Google Scholar
• Park SP, Ahn JK. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Clin Experiment Ophthalmol. 2009;37:490–495.
   PubMed Web of Science ®Google Scholar
• Spranger J, Osterhoff M, Reimann M, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 2001;50:2641–2645.
   PubMed Web of Science ®Google Scholar
• Rehak M, Hollborn M, Iandiev I, et al. Retinal gene expression and Muller cell responses after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci. 2009;50:2359–2367.
   PubMed Web of Science ®Google Scholar
• Ogata N, Tombran-Tink J, Jo N, et al. Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am J Ophthalmol. 2001;132:427–429.
   PubMed Web of Science ®Google Scholar
• Hattenbach LO, Beck KF, Pfeilschifter J, et al. Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells. Ophthalmic Res. 2005;37:341–346.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487.
   PubMed Web of Science ®Google Scholar
• Ohno-Matsui K, Yoshida T, Uetama T, et al. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun. 2003;303:962–967.
   PubMed Web of Science ®Google Scholar
• Eichler W, Yafai Y, Keller T, et al. PEDF derived from glial Muller cells: A possible regulator of retinal angiogenesis. Exp Cell Res. 2004;299:68–78.
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029–1039.
   PubMed Web of Science ®Google Scholar
• Behzadian MA, Wang XL, Shabrawey M, et al. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 1998;24:216–225.
   PubMed Web of Science ®Google Scholar
• Vinores SA, Derevjanik NL, Ozaki H, et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol. 1999;97:217–228.
   PubMed Web of Science ®Google Scholar
• Gardner TW, Antonetti DA, Barber AJ, et al. The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol. 1999;97:229–237.
   PubMed Web of Science ®Google Scholar
• Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103:1820–1828.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Matsui T, Nakamura K, et al. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. Microvasc Res 2006;72:86–90.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000;156:1733–1739.
   PubMed Web of Science ®Google Scholar
• Zhang SX, Wang JJ, Gao G, et al. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. Faseb J. 2006;20:323–325.
   PubMed Web of Science ®Google Scholar